Matthew R. Kane, President and CEO at PRECISION BIOSCIENCES INC (DTIL), sold 38,976 shares at $8.57 ($328K) on 2021-05-07, disclosed to the SEC on 2021-05-11.
Open-market sale of $328k DTIL by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.57 | 9,742 | $83K | 25.5% |
| 2 | $8.57 | 9,742 | $83K | 25.5% |
| 3 | $8.25 | 9,746 | $80K | 24.5% |
| 4 | $8.25 | 9,746 | $80K | 24.5% |
| Total | $8.41 avg | 38,976 | $328K | 100% |
| Filing → |
| DTIL | SELL | 2021-04-12 | $260K | — | Filing → |
| DTIL | SELL | 2021-03-16 | $221K | — | Filing → |
| DTIL | SELL | 2021-03-12 | $450K | — | Filing → |